TRUEBLUE INC (TBI) Forecast, Price Target & Analyst Ratings

NYSE:TBIUS89785X1019

Current stock price

3.85 USD
-0.18 (-4.47%)
At close:
3.85 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRUEBLUE INC (TBI).

Forecast Snapshot

Consensus Price Target

Price Target
$7.91
+ 105.32% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
-$0.45
Revenue Estimate
394.41M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$7.91
Upside
+ 105.32%
From current price of $3.85 to mean target of $7.91, Based on 6 analyst forecasts
Low
$5.56
Median
$7.91
High
$10.50

Price Target Revisions

1 Month
0.00%
3 Months
-8.82%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for TBI. The average price target is 7.91 USD. This implies a price increase of 105.32% is expected in the next year compared to the current price of 3.85.
The average price target has been revised downward by 8.82% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

TBI Current Analyst RatingTBI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

TBI Historical Analyst RatingsTBI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
TBI was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TBI.
In the previous month the buy percentage consensus was at a similar level.
TBI was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-05BMO CapitalMaintains Outperform -> Outperform
2025-08-06BMO CapitalMaintains Outperform -> Outperform
2024-11-05BMO CapitalMaintains Outperform -> Outperform
2024-08-07BMO CapitalMaintains Outperform -> Outperform
2024-06-17BMO CapitalMaintains Outperform -> Outperform
2024-05-08BMO CapitalMaintains Outperform -> Outperform
2024-05-07BairdMaintains Outperform -> Outperform
2023-07-26BMO CapitalMaintains Outperform -> Outperform
2023-05-22BMO CapitalUpgrade Market Perform -> Outperform
2023-04-26BMO CapitalMaintains Market Perform
2023-04-25BairdMaintains Outperform
2022-07-27BMO CapitalMaintains Market Perform
2022-07-26BairdMaintains Outperform
2022-05-26BMO CapitalDowngrade Outperform -> Market Perform
2021-04-27BairdUpgrade Neutral -> Outperform
2021-04-27Credit SuisseMaintains Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 27, 2026
Period
Q1 / 2026
EPS Estimate
-$0.45
Revenue Estimate
394.41M
Revenue Q2Q
6.52%
EPS Q2Q
-13.62%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.46%
EPS (1 Month)
0.00%
EPS (3 Months)
-350.00%

Next Earnings Summary

TBI is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is -0.45 USD and the consensus revenue estimate is 394.41M USD.
The next earnings revenue estimate has been revised upward by 0.46% in the past 3 months.

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027
Revenue
YoY % growth
TBI revenue by date.TBI revenue by date.
1.906B
-15.44%
1.567B
-17.78%
1.616B
3.10%
1.717B
6.25%
1.784B
3.90%
EBITDA
YoY % growth
TBI ebitda by date.TBI ebitda by date.
7.073M
-93.41%
-8.48M
-219.89%
-4.147M
51.10%
28.213M
780.32%
52.122M
84.74%
EBIT
YoY % growth
TBI ebit by date.TBI ebit by date.
-18.748M
-124.03%
-38.041M
-102.91%
-32.999M
13.25%
29.572M
189.61%
29.468M
-0.35%
Operating Margin
TBI operating margin by date.TBI operating margin by date.
-0.98%-2.43%-2.04%1.72%1.65%
EPS
YoY % growth
TBI eps by date.TBI eps by date.
0.35
-85.66%
-0.45
-228.57%
-0.69
-53.33%
-0.06
91.70%
0.56
1,076.41%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.45
-13.62%
0.03
143.29%
0.25
741.67%
0.11
145.79%
-0.06
86.67%
0.17
466.67%
0.33
30.00%
0.21
85.30%
Revenue
Q2Q % growth
394.41M
6.52%
420.64M
6.14%
458.71M
6.36%
443.43M
6.04%
419.55M
6.37%
444.88M
5.76%
483.01M
5.30%
472.47M
6.55%
EBITDA
Q2Q % growth
-8.203M
-57.50%
8.355M
-4.24%
16.222M
-16.10%
11.839M
-28.16%
-1.27M
84.52%
12.794M
53.13%
20.227M
24.69%
11.303M
-4.53%
EBIT
Q2Q % growth
3.654M
130.40%
6.095M
209.09%
9.512M
509.65%
10.155M
182.08%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TBI Yearly Revenue VS EstimatesTBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
TBI Yearly EPS VS EstimatesTBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

TRUEBLUE INC / TBI Forecast FAQ

What do analysts expect the price target to be for TRUEBLUE INC (TBI)?

6 analysts have analysed TBI and the average price target is 7.91 USD. This implies a price increase of 105.32% is expected in the next year compared to the current price of 3.85.

When does TRUEBLUE INC (TBI) report earnings?

TRUEBLUE INC (TBI) will report earnings on 2026-04-27.

What are the consensus estimates for TRUEBLUE INC (TBI) next earnings?

The consensus EPS estimate for the next earnings of TRUEBLUE INC (TBI) is -0.45 USD and the consensus revenue estimate is 394.41M USD.